Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,741
Total Claims
$579K
Drug Cost
200
Beneficiaries
$2,893
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,825 Geriatric Medicine providers
-92%
Opioid rate vs peers
0.2% vs 2.6% avg
+134%
Cost per patient vs peers
$2,893 vs $1,237 avg
+10%
Brand preference vs peers
10.1% vs 9.2% avg
Opioid Prescribing
0.2%
Opioid Rate
19
Opioid Claims
$215
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 880 claims · $279K
Generic: 7,844 claims · $299K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Abiraterone Acetate | 13 | $86K |
| Apixaban | 143 | $59K |
| Liraglutide | 53 | $37K |
| Sitagliptin Phosphate | 61 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 87 | $22K |
| Budesonide | 44 | $16K |
| Atovaquone | 11 | $14K |
| Iloperidone | 11 | $12K |
| Atorvastatin Calcium | 674 | $10K |
| Gabapentin | 341 | $8,654 |
| Tiotropium Bromide | 16 | $8,653 |
| Insulin Degludec | 14 | $8,622 |
| Insulin Lispro | 16 | $8,096 |
| Tiotropium Bromide | 14 | $7,666 |
| Empagliflozin | 20 | $7,629 |
Prescribing Profile
Patient Profile
75
Avg Age
51%
Female
2.57
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About